ANNX Annexon, Inc.
Nasdaq · SEC CIK 1528115 · EDGAR
- Bought, last 12 months
- $12.32M 11 purchases by 3 insiders
- Sold, last 12 months
- $313.4K 10 sales by 5 insiders
- Filings on record
- 146 since 2021-08-16, latest 2026-08-12 18:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Satter Muneer A | Dir | $11.97M | — |
| Carson William H. | Dir | $205.8K | — |
| Choi Jung | Dir | $138.3K | — |
| Yednock Ted | EVP, Chief INNOVATION Off | — | $70.3K |
| Lew Jennifer | EVP, CFO | — | $70.3K |
| ARTIS DEAN RICHARD | EVP, CSO | — | $59.0K |
| Dananberg Jamie | Chief MEDICAL Off | — | $58.6K |
| Overdorf Michael | EVP, Chief BUSINESS Off | — | $55.3K |
Transactions 110
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-15 16:15 | 2026-06-11 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | M - OptEx | $1.85 | +30.6K | 184.8K | +20% | +$56.7K |
| I | 2026-05-29 17:21 | 2026-05-28 | ANNX | Satter Muneer A | Dir | P - Purchase | $5.41 | +613.5K | 10.34M | +6% | +$3.32M |
| T | 2026-05-13 16:30 | 2026-05-11 | ANNX | Carson William H. | Dir | P - Purchase | $5.78 | +8,000 | 78.4K | +11% | +$46.2K |
| T | 2026-04-14 16:16 | 2026-04-10 | ANNX | Carson William H. | Dir | P - Purchase | $6.20 | +8,000 | 70.4K | +13% | +$49.6K |
| 2026-03-12 | 2026-03-10 | ANNX | Carson William H. | Dir | P - Purchase | $5.67 | +8,000 | 62.4K | +15% | +$45.4K | |
| 2026-03-04 | 2026-03-02 | ANNX | Dananberg Jamie | Chief MEDICAL Off | S - Sale | $5.43 | -5,820 | 123.6K | -4% | -$31.6K | |
| 2026-03-04 | 2026-03-02 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | S - Sale | $5.43 | -5,894 | 180.1K | -3% | -$32.0K | |
| 2026-03-04 | 2026-03-02 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.42 | -5,565 | 170.7K | -3% | -$30.2K | |
| 2026-03-04 | 2026-03-02 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.42 | -5,566 | 154.2K | -3% | -$30.2K | |
| 2026-03-04 | 2026-03-02 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $5.42 | -4,339 | 182.6K | -2% | -$23.5K | |
| D | 2026-02-23 | 2026-02-19 | ANNX | Dananberg Jamie | Chief MEDICAL Off | A - Grant | $0.00 | +56.2K | 129.4K | +77% | $0 |
| D | 2026-02-23 | 2026-02-19 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | A - Grant | $0.00 | +62.5K | 186.0K | +51% | $0 |
| D | 2026-02-23 | 2026-02-19 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | A - Grant | $0.00 | +62.5K | 159.7K | +64% | $0 |
| D | 2026-02-23 | 2026-02-19 | ANNX | Lew Jennifer | EVP, CFO | A - Grant | $0.00 | +62.5K | 176.3K | +55% | $0 |
| D | 2026-02-23 | 2026-02-19 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | A - Grant | $0.00 | +62.5K | 187.0K | +50% | $0 |
| 2026-02-20 | 2026-02-18 | ANNX | Dananberg Jamie | Chief MEDICAL Off | S - Sale | $5.10 | -5,290 | 73.2K | -7% | -$27.0K | |
| 2026-02-20 | 2026-02-18 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $5.10 | -6,225 | 124.5K | -5% | -$31.7K | |
| 2026-02-20 | 2026-02-18 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.11 | -7,857 | 97.2K | -7% | -$40.1K | |
| 2026-02-20 | 2026-02-18 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.11 | -7,851 | 113.8K | -6% | -$40.1K | |
| 2026-02-20 | 2026-02-18 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | S - Sale | $5.10 | -5,290 | 123.5K | -4% | -$27.0K | |
| 2026-01-02 | 2025-12-30 | ANNX | Carson William H. | Dir | P - Purchase | $5.02 | +4,115 | 54.4K | +8% | +$20.7K | |
| 2025-12-03 | 2025-12-01 | ANNX | Carson William H. | Dir | P - Purchase | $4.47 | +4,115 | 50.3K | +9% | +$18.4K | |
| I | 2025-12-03 | 2025-12-01 | ANNX | Choi Jung | Dir | P - Purchase | $4.19 | +33.0K | 33.0K | New | +$138.3K |
| MI | 2025-11-21 | 2025-11-20+ | ANNX | Satter Muneer A | Dir | P - Purchase | $4.38 | +822.6K | 9.31M | +10% | +$3.60M |
| MI | 2025-11-19 | 2025-11-17+ | ANNX | Satter Muneer A | Dir | P - Purchase | $3.37 | +1.50M | 8.41M | +22% | +$5.05M |
| 2025-10-31 | 2025-10-30 | ANNX | Carson William H. | Dir | P - Purchase | $3.17 | +4,115 | 46.2K | +10% | +$13.0K | |
| 2025-10-02 | 2025-09-30 | ANNX | Carson William H. | Dir | P - Purchase | $3.05 | +4,115 | 42.1K | +11% | +$12.6K | |
| 2025-09-04 | 2025-09-02 | ANNX | Carson William H. | Dir | P - Purchase | $2.09 | +4,115 | 37.9K | +12% | +$8,600 | |
| 2025-08-01 | 2025-07-30 | ANNX | Carson William H. | Dir | P - Purchase | $2.43 | +4,115 | 33.8K | +14% | +$9,999 | |
| 2025-07-16 | 2025-07-14 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $2.61 | -853 | 130.7K | -0.6% | -$2,226 | |
| 2025-07-16 | 2025-07-14 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $2.58 | -1,117 | 121.6K | -0.9% | -$2,882 | |
| 2025-07-16 | 2025-07-14 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $2.58 | -1,116 | 105.1K | -1% | -$2,879 | |
| 2025-07-01 | 2025-06-30 | ANNX | Carson William H. | Dir | P - Purchase | $2.46 | +4,115 | 29.7K | +16% | +$10.1K | |
| D | 2025-03-03 | 2024-02-27 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | A - Grant | $0.00 | +45.0K | 106.2K | +73% | $0 |
| D | 2025-03-03 | 2024-02-27 | ANNX | Lew Jennifer | EVP, CFO | A - Grant | $0.00 | +45.0K | 122.7K | +58% | $0 |
| D | 2025-03-03 | 2024-02-27 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | A - Grant | $0.00 | +45.0K | 128.8K | +54% | $0 |
| D | 2025-03-03 | 2024-02-27 | ANNX | Dananberg Jamie | Chief MEDICAL Off | A - Grant | $0.00 | +45.0K | 78.4K | +134% | $0 |
| D | 2025-03-03 | 2024-02-27 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | A - Grant | $0.00 | +45.0K | 131.5K | +52% | $0 |
| 2025-02-20 | 2025-02-18 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $2.92 | -6,912 | 77.8K | -8% | -$20.2K | |
| 2025-02-20 | 2025-02-18 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | S - Sale | $2.97 | -5,515 | 83.8K | -6% | -$16.4K | |
| 2025-02-20 | 2025-02-18 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $2.95 | -6,618 | 86.6K | -7% | -$19.5K | |
| 2025-02-20 | 2025-02-18 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $2.91 | -8,345 | 61.2K | -12% | -$24.3K | |
| 2025-02-20 | 2025-02-18 | ANNX | Dananberg Jamie | Chief MEDICAL Off | S - Sale | $2.96 | -5,521 | 33.5K | -14% | -$16.3K | |
| 2025-02-18 | 2025-02-13 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $2.98 | -1,786 | 84.7K | -2% | -$5,322 | |
| 2025-02-18 | 2025-02-13 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $2.99 | -1,425 | 93.2K | -2% | -$4,261 | |
| 2025-02-18 | 2025-02-13 | ANNX | Love Douglas | Pres AND CEO, Dir | S - Sale | $2.95 | -5,021 | 351.6K | -1% | -$14.8K | |
| 2025-02-18 | 2025-02-13 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $2.99 | -1,783 | 69.6K | -2% | -$5,331 | |
| D | 2025-01-08 | 2025-01-06 | ANNX | Love Douglas | Pres AND CEO, Dir | M - OptEx | $1.41 | +38.0K | 356.6K | +12% | +$53.6K |
| 2024-12-04 | 2024-12-02 | ANNX | Carson William H. | Dir | P - Purchase | $5.33 | +3,200 | 25.6K | +14% | +$17.1K | |
| DM | 2024-11-01 | 2024-10-30 | ANNX | Love Douglas | Pres AND CEO, Dir | M - OptEx | $1.85 | +114.4K | 310.6K | +58% | +$211.7K |
| D | 2024-10-17 | 2024-10-15 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | M - OptEx | $1.85 | +5,408 | 76.8K | +8% | +$10.0K |
| D | 2024-10-17 | 2024-10-15 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale+OE | $7.41 | -5,408 | 71.4K | -7% | -$40.1K |
| 2024-10-02 | 2024-10-01 | ANNX | Carson William H. | Dir | P - Purchase | $5.97 | +3,200 | 22.4K | +17% | +$19.1K | |
| I | 2024-09-20 | 2024-09-19 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $7.10 | -4,500 | 0 | -100% | -$31.9K |
| I | 2024-09-16 | 2024-09-12 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $6.16 | -5,500 | 4,500 | -55% | -$33.9K |
| I | 2024-09-06 | 2024-09-05 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.64 | -5,500 | 10.0K | -35% | -$31.0K |
| 2024-09-04 | 2024-09-03 | ANNX | Carson William H. | Dir | P - Purchase | $5.48 | +3,200 | 19.2K | +20% | +$17.5K | |
| I | 2024-08-30 | 2024-08-29 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.95 | -5,500 | 15.5K | -26% | -$32.7K |
| 2024-08-05 | 2024-08-01 | ANNX | Carson William H. | Dir | P - Purchase | $6.24 | +3,200 | 16.0K | +25% | +$20.0K | |
| 2024-07-17 | 2024-07-15 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $6.02 | -1,106 | 71.4K | -2% | -$6,658 | |
| 2024-07-17 | 2024-07-15 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $6.02 | -784 | 94.6K | -0.8% | -$4,720 | |
| 2024-07-17 | 2024-07-15 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $6.03 | -1,104 | 86.5K | -1% | -$6,657 | |
| 2024-07-02 | 2024-07-01 | ANNX | Carson William H. | Dir | P - Purchase | $5.00 | +3,200 | 12.8K | +33% | +$16.0K | |
| 2024-06-05 | 2024-06-03 | ANNX | Carson William H. | Dir | P - Purchase | $4.83 | +3,200 | 9,600 | +50% | +$15.5K | |
| 2024-05-03 | 2024-05-01 | ANNX | Carson William H. | Dir | P - Purchase | $4.68 | +3,200 | 6,400 | +100% | +$15.0K | |
| 2024-04-10 | 2024-04-08 | ANNX | Carson William H. | Dir | P - Purchase | $6.07 | +3,200 | 3,200 | New | +$19.4K | |
| D | 2024-02-21 | 2024-02-16 | ANNX | Lew Jennifer | EVP, CFO | A - Grant | $0.00 | +39.0K | 84.7K | +85% | $0 |
| D | 2024-02-21 | 2024-02-20 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.53 | -2,593 | 82.1K | -3% | -$14.3K |
| D | 2024-02-21 | 2024-02-16 | ANNX | Dananberg Jamie | Chief MEDICAL Off | A - Grant | $0.00 | +39.0K | 39.0K | New | $0 |
| D | 2024-02-21 | 2024-02-16 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | A - Grant | $0.00 | +39.0K | 75.1K | +108% | $0 |
| D | 2024-02-21 | 2024-02-20 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.51 | -2,604 | 72.5K | -3% | -$14.3K |
| D | 2024-02-21 | 2024-02-16 | ANNX | ARTIS DEAN RICHARD | EVP, CSO | A - Grant | $0.00 | +39.0K | 89.3K | +77% | $0 |
| D | 2024-02-21 | 2024-02-16 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | A - Grant | $0.00 | +39.0K | 87.6K | +80% | $0 |
| D | 2024-02-21 | 2024-02-20 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $5.48 | -1,951 | 85.6K | -2% | -$10.7K |
| 2024-02-14 | 2024-02-12 | ANNX | Yednock Ted | EVP, Chief INNOVATION Off | S - Sale | $5.54 | -1,810 | 36.1K | -5% | -$10.0K | |
| 2024-02-14 | 2024-02-12 | ANNX | Love Douglas | Pres AND CEO, Dir | S - Sale | $5.54 | -5,782 | 196.1K | -3% | -$32.0K | |
| 2024-02-14 | 2024-02-12 | ANNX | Overdorf Michael | EVP, Chief BUSINESS Off | S - Sale | $5.53 | -1,349 | 48.6K | -3% | -$7,460 | |
| 2024-02-14 | 2024-02-12 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $5.54 | -1,809 | 45.7K | -4% | -$10.0K | |
| 2024-01-23 | 2023-07-11 | ANNX | Overdorf Michael | EVP, Chief Business Off | S - Sale | $3.84 | -978 | 45.8K | -2% | -$3,756 | |
| 2024-01-23 | 2023-07-11 | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $3.84 | -1,057 | 47.5K | -2% | -$4,059 | |
| MA | 2024-01-23 | 2023-07-11+ | ANNX | Yednock Ted | EVP, Chief Innovation Off | S - Sale+OE | $4.49 | -22.1K | 37.9K | -37% | -$99.0K |
| MA | 2024-01-23 | 2023-12-27 | ANNX | Yednock Ted | EVP, Chief Innovation Off | M - OptEx | $1.63 | +21.0K | 48.5K | +76% | +$34.2K |
| DM | 2023-12-29 | 2023-12-27 | ANNX | Yednock Ted | EVP, Chief Innovation Off | M - OptEx | $1.63 | +21.0K | 10.6K | New | +$34.2K |
| D | 2023-12-29 | 2023-12-27 | ANNX | Yednock Ted | EVP, Chief Innovation Off | S - Sale+OE | $4.52 | -21.0K | 0 | -100% | -$94.9K |
| I | 2023-12-28 | 2023-12-26 | ANNX | Satter Muneer A | Dir, 10% | P - Purchase | $2.88 | +350.0K | 7.41M | +5% | +$1.01M |
| I | 2023-05-30 | 2023-05-25 | ANNX | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $2.13 | +300.0K | 5.70M | +6% | +$639.0K |
| D | 2023-02-21 | 2023-02-16 | ANNX | Overdorf Michael | EVP, Chief Business Off | A - Grant | $0.00 | +19.0K | 46.8K | +68% | $0 |
| D | 2023-02-21 | 2023-02-16 | ANNX | Lew Jennifer | EVP, CFO | A - Grant | $0.00 | +19.0K | 48.5K | +64% | $0 |
| 2023-02-17 | 2023-02-15 | ANNX | Love Douglas | Pres, CEO, Dir | S - Sale | $5.87 | -6,571 | 197.6K | -3% | -$38.6K | |
| M | 2023-02-15 | 2023-02-13+ | ANNX | Lew Jennifer | EVP, CFO | S - Sale | $6.31 | -1,908 | 29.7K | -6% | -$12.0K |
| M | 2023-02-15 | 2023-02-13+ | ANNX | Overdorf Michael | EVP, Chief Business Off | S - Sale | $6.30 | -1,645 | 27.8K | -6% | -$10.4K |
| I | 2023-02-14 | 2023-02-10 | ANNX | Satter Muneer A | Dir, 10% | P - Purchase | $6.80 | +2.65M | 7.06M | +60% | +$18.00M |
| D | 2022-07-13 | 2022-07-11 | ANNX | Overdorf Michael | EVP, Chief Business Off | A - Grant | $0.00 | +9,375 | 21.9K | +75% | $0 |
| D | 2022-07-13 | 2022-07-11 | ANNX | Lew Jennifer | EVP, CFO | A - Grant | $0.00 | +9,375 | 23.9K | +65% | $0 |
| D | 2022-07-13 | 2022-07-11 | ANNX | Mattheakis Larry | EVP, CSO | A - Grant | $0.00 | +4,688 | 17.2K | +38% | $0 |
| D | 2022-07-13 | 2022-07-11 | ANNX | Mattheakis Larry | EVP, CSO | A - Grant | $0.00 | +4,688 | 17.2K | +38% | $0 |
| DI | 2022-07-11 | 2022-07-07 | ANNX | Satter Muneer A | Dir | P - Purchase | $3.84 | +2.45M | 4.41M | +126% | +$9.42M |
| 2022-04-18 | 2022-04-14 | ANNX | Love Douglas | Pres, CEO, Dir | P - Purchase | $2.45 | +60.0K | 200.9K | +43% | +$147.0K | |
| D | 2022-02-15 | 2022-02-11 | ANNX | Keswani Sanjay | EVP, Chief Medical Off | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
| D | 2022-02-15 | 2022-02-11 | ANNX | Overdorf Michael | EVP, Chief Business Off | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations